Integrase inhibitor MK-0518: Merck opens expanded-access program.

Article Details

Citation
Copy to clipboard

James JS

Integrase inhibitor MK-0518: Merck opens expanded-access program.

AIDS Treat News. 2006 Jul-Sep;(419):5.

PubMed ID
17096488 [ View in PubMed
]
Abstract

Patients resistant to at least one drug in all three oral classes may qualify for this new kind of antiretroviral--which still must be combined with other active drugs.

DrugBank Data that Cites this Article

Drugs